Heart Failure 2026 - Reviewing CCS 2025 Heart Failure Guidelines
Heart Failure 2026 Gordon Moe, MD, FRCPC, FACC, FAHA Director, Heart Failure Program St. Michael's Hospital Professor of Medicine, University of Toronto January 19, 2026 12:00 - 1:00 P.M. ET Objectives: 1. Review recent late-breaking clinical trials and their clinical applications. 2. Evaluate the 2025 CCS heart failure guideline.
▶︎
Diagnosis and Treatment of Heart Failure with Preserved Ejection Fraction
▶︎
Heart Failure 2026: The Current State and Future Directions of Heart Failure Management
▶︎
Beta-Blockers After MI in 2026:Lessons From Past and Present
▶︎
Core Curriculum - CCS Heart Failure with non-reduced EF Guidelines 2025: a Review
▶︎
Contemporary Approaches to Smoking Cessation and Emerging Nicotine Products
▶︎
My Coronary Plaque Dropped 48% in 16 Months: What the AI Scan Actually Showed | Dr Campbell Rogers
▶︎
The final filmed interview with Sir Alex Younger, the late MI6 chief | The Economist
▶︎
Your Heart Failure Treatment Is Outdated—Here's the New 2026 Standard Guidelines
▶︎
Arrhythmogenic Right Ventricular Cardiomyopathy: Guidelines and a Clinical Overview
▶︎
Heart Failure 2026: Update on Therapy
▶︎
Iron Deficiency in Heart Failure: Why, When, and How to Treat
▶︎
Update on the Management of Atrial Fibrillation:Focus on the New Guidelines
▶︎
Edwards' Larry Wood discusses TAVR evolution, new clinical paradigms, and addressing treatment gaps
▶︎
Blood Transfusion in Acute Coronary Syndromes: The Evidence Behind the 2025 CCS/NAC Joint Statement
▶︎
Heart Failure with Preserved Ejection Fraction (HFpEF)
▶︎
Is Your Heart Failure Strategy Outdated? | 2026 JACC Review
▶︎
I'm a Vascular Surgeon — Stop Getting Repeat CAC Scans. Here's Why
▶︎
Nobody Explained the Schrödinger Equation Like THIS!
▶︎
Assessing Heart Failure with Preserved Ejection Fraction
▶︎